O. Z. Svarchevska

Bio: O. Z. Svarchevska is an academic researcher from Lviv National University of Veterinary Medicine and Biotechnologies. The author has contributed to research in topics: Carbohydrate metabolism & Vanadium. The author has an hindex of 1, co-authored 4 publications receiving 1 citations.

Hematological parameters and protein metabolism in the blood of pregnant rats under the effect of vanadium citrate

Abstract: Dose-dependent changes in protein metabolism in the blood and hematological parameters of pregnant rats under the effect of vanadium citrate are presented in the article. The animals were divided into five groups: group I – non-pregnant females, II – pregnant females consuming pure water without additives, III, IV, V – females which during the mating and pregnancy period received the solution of vanadium citrate at concentrations of 0.03, 0.125 and 0.50 μg V/mL water. The research findings show that in pregnant animals of group II, the level of urea and alkaline phosphatase activity increased, meanwhile aspartate aminotransferase activity decreased, as compared to the non-pregnant females of group І. The levels of total protein and albumin decreased; however, the content of β-globulins increased in the pregnant animals of group II, as compared with that in group I. Also, in the rats of group II, there was a decrease in hemolysis time, total content of erythrocytes and hemoglobin, the content of old and mature erythrocytes, while the content of young erythrocytes increased, as compared to group I. The platelet content and thrombocrit in rats of group II increased in comparison with group I. The content of leukocytes and lymphocytes in pregnant animals of group II decreased, while the content of granulocytes increased, in contrast to non-pregnant rats. Under the effect of vanadium citrate at concentrations of 0.03–0.50 μg V/mL, there was a significant increase in the maximum number of prohemolized erythrocytes, the time of maximum hemolysis was delayed by 0.4–0.6 min, as compared with the pregnant rats of group II. This did not affect the time of total hemolysis in rats of groups III and V, as compared with the pregnant animals in group II. Under the effect of vanadium citrate, an increase in the content of young erythrocytes was observed, as compared with group II. The hemoglobin content decreased at the concentration of 0.125 μg V/mL, while at the concentration of 0.50 μg V/mL it increased, as compared to the pregnant animals of group II. Also, under the effect of vanadium citrate there was a decrease in the mean hemoglobin concentration in the erythrocyte. In pregnant animals fed with vanadium citrate solutions, the platelet content and thrombocrit, the relative width of platelet distribution by volume decreased, as compared with the pregnant rats of group II. The content of leukocytes, lymphocytes and granulocytes under the effect of vanadium citrate increased, as compared with the pregnant animals in group II. Under the effect of vanadium citrate at the concentration of 0.03 μg V/mL, the level of albumin, creatinine and aspartate aminotransferase activity increased in blood plasma in comparison with group II. Meanwhile, at the concentration of 0.125 μg V/mL, the relative content of γ-globulins and aspartate aminotransferase activity increased, alkaline phosphatase activity and urea level decreased in comparison with group II. However at the concentration of 0.50 μg V/mL, the relative α- and γ-globulins content and aspartate aminotransferase activity increased, at the same time, the relative β-globulins content and urea level decreased in comparison with group II. Therefore, vanadium citrate normalizes the indicators of protein metabolism during pregnancy, thus it can be considered as a potential dietary drug for the pregnant.

Вплив магній цитрату на вміст ліпідів у плазмі крові щурів за умов експериментального цукрового діабету

Abstract: Досліджено вплив різних доз магній цитрату (100, 250 і 500 мг Mg2+/кг маси тіла) на вміст ліпідів у плазмі крові щурів з алоксан-індукованим цукровим діабетом. Установлено, що в плазмі крові щурів з експериментальним діабетом підвищувався вміст загальних ліпідів, що супроводжувалося змінами в класах ліпідів плазми крові. Проте з’ясовано, що магній цитрат, який протягом чотирьох тижнів разом із питною водою додавався до раціону тварин, зумовлював стабілізацію досліджуваних показників із наближенням їх до рівня в контрольній групі.

Effects of the complex of magnesium and chromium citrates on the carbohydrate metabolism in the blood of rats with experimental diabetes mellitus

Abstract: The article presents the results of investigation of the influence of the complex of magnesium (Mg2+) and chromium (Cr3+) citrates on the activity of carbohydrate metabolism key enzymes, and also on the concentration of insulin and C-peptide in the blood of rats with experimental diabetes. The complex of magnesium and chromium citrates in doses 250 mg Mg/kg bw plus 25 mkg Cr/kg bw and 250 mg Mg/kg bw plus 10 mkg Cr/kg bw was added to the drinking water for all animals during 30 days. Experimental diabetes in animals was induced by a single intraperitoneal administration of a solution of alloxane monohydrate (“Synbios”) at a dose of 150 mg/kg body weight. The glucose-6-phosphate dehydrogenase (G-6-PDH) and lactate dehydrogenase (LDH) activities in erythrocyte lizates, glucose, insulin and C-peptide concentrations in blood plasma were investigated. It was found that experimental diabetes indused the decreased of glucose-6-phosphate dehydrogenase activity, insulin and C-peptide concentrations, and the increased lactate dehydrogenase activity and glucose concentration. The complex of magnesium and chromium citrates, which was added with water to the animals’ diet during four weeks, led to a positive normalizing effect. It was shown by a credible increase of insulin and C-peptide concentrations and followed by a decrease of glucose concentration in the blood plasma. Thus received results demonstrate that the addition of the investigated complex compound may become a basis for a development a new methods, which will help to correct the emergence and development of complications for diabetes mellitus in future.

Vanadium pentoxide induce hematological, oxidative stress and histological changes in Oryctolagus cuniculus

Abstract: The effects of vanadium pentoxide (V2O5) on hematological, oxidative stress biomarkers, and histopathological status of male Oryctolagus cuniculus were investigated on a 21-day exposure trial and 7-days recovery. Oryctolagus cuniculus (433.45 ± 5.00 g) were randomized into four experimental and one control groups each in triplicate of four animals. A 96-h estimated median lethal dose (LD50) of 119.0 mg/kg was used to derive four experimental daily oral doses (1, 5, 10 and 20 mg/kg body weight) of V2O5; while the control received distilled water instead. Hematological and oxidative stress biomarkers were evaluated on day-7 (d-7), d-14, d-21 and 7-d withdrawal, whereas histopathology was assessed on d-21 and 7-d withdrawal. After 21-d exposure to 20 mg/kg of V2O5, the red blood cell count (RBC) and hemoglobin concentration (Hb) decreased by 16.9% and 12.3% respectively, while the white blood cell count (WBC) increased by 6.7% compared to the control. The activities of catalase and superoxide dismutase decreased by as much as 30.0% and 14.3% respectively compared to the control in rabbits exposed to 20 mg/kg of V2O5. Lipid peroxidation increased from exposure to V2O5, and peaked on d-7 (∼ 42.9 – 61.0% above the control). Changes in oxidative stress biomarkers were dose- and time-dependent. Sections of the liver and kidney of exposed animals showed alterations in tissue architecture that were characterized by inflammatory cells infiltration, sinusoidal congestion, renal cast formation and vacuolar and tubular degeneration. Taken together, exposure to V2O5 exerts hematological, oxidative stress and histopathological changes in O. cuniculus and calls for strict restriction on the use of this compound to avert environmental hazard.